Theodore S. Hong

Also affiliated with Beth Israel Deaconess Medical Center, Harvard University, Princess Margaret Cancer Centre, Massachusetts General Hospital, Dana-Farber Cancer Institute, Center for Cancer Research, Mass General Brigham

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

(2023)10.1158/1078-0432.c.6531324

Top 100%

0DataRank

Top 100%0 citations

Jeffrey W. Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Papers

Driven by 58 papers — median percentile 0. Top paper: “Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment”.

Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.25.267336

N/A

1.6DataRank · unranked

35 citations

Karthik A. Jagadeesh, Jimmy A. Guo, Hannah I. Hoffman, Payman Yadollahpour, Rahul Mohan +46 more

Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0331

N/A

0.824DataRank · unranked

13 citations

Jeffrey W. Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer

BMC Cancer(2024)10.1186/s12885-024-12529-7

N/A

0.808DataRank · unranked

39 citations

Qian Shi, Arvind Dasari, Julio García‐Aguilar, Hanna Sanoff, Thomas J. George +25 more

Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-1630

N/A

0.596DataRank · unranked

52 citations

Jessica M. Posada, Sonu Subudhi, Ashwin S. Kumar, Spencer R. Rosario, Liqun Gu +13 more

Long-term results from NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.7

N/A

0.561DataRank · unranked

41 citations

Greg Yothers, Osama E. Rahma, Theodore S. Hong, Marcia M. Russell, Y. Nancy You +14 more

Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies

Theranostics(2024)10.7150/thno.100116

N/A

0.442DataRank · unranked

18 citations

Hua Ma, Shriya Krishna, Sergey Shuvaev, Mark F Sabbagh, Caitlin Deffler +21 more

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

BMC Cancer(2024)10.1186/s12885-024-11899-2

N/A

0.324DataRank · unranked

4 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps212

N/A

0.312DataRank · unranked

7 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +8 more

Utilizing Patient Input in Rectal Cancer Trial Design

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf074

N/A

0.241DataRank · unranked

4 citations

Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher, Caleah Kitchens +22 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3643

N/A

0.208DataRank · unranked

3 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +9 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3634

N/A

0.104DataRank · unranked

1 citations

Yu Guan, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Ibrahim Halil Sahin +10 more

Results and molecular correlates from a pilot study of neoadjuvant induction FOLFIRINOX followed by chemoradiation and surgery for gastroesophageal adenocarcinomas

Research Square(2020)10.21203/rs.3.rs-92371/v1

N/A

0.104DataRank · unranked

1 citations

Jeffrey Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Current treatment and future directions in the management of anal cancer

CA A Cancer Journal for Clinicians(2021)10.3322/caac.21712

N/A

0DataRank · unranked

27 citations

Cathy Eng, Craig Messick, Theodore S. Hong, Ethan B. Ludmir, Lisa A. Kachnic +2 more

Screening and Validation of Molecular Targeted Radiosensitizers

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.07.1694

N/A

0DataRank · unranked

21 citations

Xiao Pan, Nathalie Borgeaud, Irina Korovina, Lydia Koi, Regina K. Egan +17 more

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—Pembrolizumab experimental arm (EA) primary results.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.8

N/A

0DataRank · unranked

32 citations

Greg Yothers, Theodore S. Hong, Marcia M. Russell, Y. Nancy You, William Parker +10 more

The use of elevated circulating hepatocyte growth factor (HGF) level as a potential prognostic biomarker in locally advanced pancreatic cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.429

N/A

0DataRank · unranked

3 citations

Jennifer Y. Wo, Beow Y. Yeap, Christine A. Ulysse, Janet E. Murphy, Colin D. Weekes +10 more

NRG Oncology NRG-GI007 trial-in-progress: Phase I study of OBP-301 (Telomelysin) and definitive chemoradiation (CRT) for patients with locally advanced esophageal and gastroesophageal adenocarcinoma who are not candidates for surgery.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps262

N/A

0DataRank · unranked

1 citations

Kathryn Winter, Terence M. Williams, Prasad S. Adusumilli, Makoto Nishimura, Adam D. Yock +3 more

Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4165

N/A

0DataRank · unranked

88 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1117

N/A

0DataRank · unranked

60 citations

Aparna R. Parikh, Alexander Solovyov, Eunae You, Anupriya S. Kulkarni, Chong Chu +44 more

Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers

International Journal of Molecular Sciences(2022)10.3390/ijms23041926

N/A

0DataRank · unranked

4 citations

Hannah Roberts, Theodore S. Hong, Dan G. Duda, Franziska Hauth

Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3647

N/A

0DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps233

N/A

0DataRank · unranked

3 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +8 more

IFNA pathway drives the more aggressive phenotype of KRAS G12D -mutant pancreatic ductal adenocarcinomas via IFNAR1/STAT3 activation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.29.497540

N/A

0DataRank · unranked

0 citations

Daniel H. Schanne, Aya Matsui, Pin‐Ji Lei, Sebastian Klein, Shuichi Aoki +20 more

Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.01.054

N/A

0DataRank · unranked

26 citations

Jungwook Shin, Stella Xing, Chris Beekman, Jan Schuemann, Theodore S. Hong +10 more

Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0792

N/A

0DataRank · unranked

17 citations

Yuzhen Zhou, Keisuke Otani, Michael Drumm, Yukako Otani, Shulin Wu +17 more

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases

Liver Cancer(2023)10.1159/000530134

N/A

0DataRank · unranked

13 citations

Rituraj Upadhyay, Kaiping Liao, Tiffany Kumala, Christopher Shi, Grace Dodoo +24 more

NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.489

N/A

0DataRank · unranked

60 citations

Kathryn Winter, Jennifer J. Knox, Andrew X. Zhu, Sunil Krishnan, Chandan Guha +15 more

Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3640

N/A

0DataRank · unranked

21 citations

Arvind Dasari, Qian Shi, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +13 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps258

N/A

0DataRank · unranked

1 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps259

N/A

0DataRank · unranked

1 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +8 more

Alliance A022101: A pragmatic, randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3629

N/A

0DataRank · unranked

1 citations

Paul B. Romesser, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

Research Square(2023)10.21203/rs.3.rs-3773522/v1

N/A

0DataRank · unranked

1 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

NRG GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps260

N/A

0DataRank · unranked

0 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +10 more

Data from Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

(2023)10.1158/1078-0432.c.6531324

Top 100%

0DataRank

Top 100%0 citations

Jeffrey W. Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Data from Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

(2023)10.1158/1078-0432.c.6531324.v1

Top 100%

0DataRank

Top 100%0 citations

Jeffrey W. Clark, Christine E. Eyler, Mari Mino–Kenudson, Samuel J. Klempner, Jill N. Allen +20 more

Data from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

(2023)10.1158/1078-0432.c.6530634

N/A

0DataRank · unranked

0 citations

Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich, Yupeng He +38 more

Data from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

(2023)10.1158/1078-0432.c.6530634.v1

N/A

0DataRank · unranked

0 citations

Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich, Yupeng He +38 more

Data from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

(2023)10.1158/1078-0432.c.6532688

N/A

0DataRank · unranked

0 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Data from Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response

(2023)10.1158/1078-0432.c.6532688.v1

N/A

0DataRank · unranked

0 citations

Jacquelyn W. Zimmerman, Reecha Suri, Haley Zlomke, Gabriel D. Ivey, Annamária Szabolcs +17 more

Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

(2023)10.1158/2159-8290.c.6549619.v1

N/A

0DataRank · unranked

0 citations

Aparna R. Parikh, Alexander Solovyov, Eunae You, Anupriya S. Kulkarni, Chong Nam Chu +44 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3625

N/A

0DataRank · unranked

0 citations

Greg Yothers, Scott Kopetz, Shannon L. Puhalla, Peter C. Lucas, Atif Iqbal +8 more

Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment

Nature Genetics(2024)10.1038/s41588-024-01890-9

N/A

0DataRank · unranked

72 citations

Jingyi Cao, Dennis Gong, Mark Gregory, Nicholas J Caldwell, Xunqin Yin +27 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps3633

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2024.12.034

N/A

0DataRank · unranked

1 citations

Bailey Nelsonn, Julie L. Koenig, John P. Plastaras, James M. Metz, Beow Y. Yeap +13 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3634

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Trials in progress: Alliance A022104/NRG-GI010—A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer (LARC; the Janus Rectal Cancer trial).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3650

N/A

0DataRank · unranked

0 citations

Qian Shi, Arvind Dasari, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +15 more

The Pdgfd-Pdgfrb axis orchestrates tumor-nerve crosstalk in pancreatic cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.26.672505

N/A

0DataRank · unranked

0 citations

Nicole A. Lester, Ella Perrault, Jennifer Su, Dennis Gong, Carina Shiau +33 more

Single-nucleus RNA-seq of frozen archival primary pancreatic ductal adenocarcinoma uncovers multi-compartment intratumoral heterogeneity associated with neoadjuvant treatment.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4633

N/A

0DataRank · unranked

0 citations

Hannah I. Hoffman, Orr Ashenberg, Eugene Drokhlyansky, Nicholas Van Wittenberghe, Samouil Farhi +18 more

Modern Radiation Therapy Approaches: Targeted and Ablative Strategies

Interventional Oncology(2012)10.1007/978-1-4419-1469-9_2

N/A

0DataRank · unranked

0 citations

Theodore S. Hong

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3467

N/A

0DataRank · unranked

143 citations

Amikasra Mojtahed, Jaime L. Schneider, Katie Kanter, Emily E. Van Seventer, Isobel J. Fetter +25 more

Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.04.027

N/A

0DataRank · unranked

69 citations

Issam El Naqa, Nina N. Sanford, B. Noe, Jennifer Y. Wo, Christine E. Eyler +7 more

Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target

Nature Communications(2020)10.1038/s41467-020-17150-3

N/A

0DataRank · unranked

90 citations

Julia Philipp, Pavlos Missios, Irun Bhan, Ann Liu, Chittampalli N. Yashaswini +17 more

A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy

Radiotherapy and Oncology(2020)10.1016/j.radonc.2020.07.025

N/A

0DataRank · unranked

50 citations

Clemens Grassberger, Aimee L. McNamara, Lucas Basler, Stefanie Ehrbar, Stephanie Tanadini‐Lang +3 more

Socioeconomic determinants of the surgical treatment of colorectal liver metastases

The American Journal of Surgery(2020)10.1016/j.amjsurg.2020.02.019

N/A

0DataRank · unranked

16 citations

Neha Shafique, Hang Lee, Grace C. Lee, Kenneth K. Tanabe, Cristina R. Ferrone +5 more

Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4500

N/A

0DataRank · unranked

36 citations

Kathryn Winter, Dennis A. Wigle, Thomas A. DiPetrillo, Michael G. Haddock, Theodore S. Hong +15 more

Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma

Gut(2021)10.1136/gutjnl-2020-322493

N/A

0DataRank · unranked

81 citations

Koetsu Inoue, Sebastian Klein, Stefan Halvorsen, Jiang Chen, Aya Matsui +28 more

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

Journal of Hepatocellular Carcinoma(2021)10.2147/jhc.s282062

N/A

0DataRank · unranked

47 citations

Sweet Ping Ng, Amy Liu, Santiago Avila, Randa Tao, Emma B. Holliday +19 more

Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma

Journal of Clinical Oncology(2021)10.1200/jco.21.01220

N/A

0DataRank · unranked

31 citations

Laura A. Dawson, Theodore S. Hong, Manisha Palta, Joseph M. Herman, Douglas B. Evans +12 more

Theodore S. Hong

Indexed papers

Top data-sharing exemplar

Papers